Research brief
A team at the First Hospital of Shanxi Medical University has crafted a nomogram designed to predict baseline respiratory insufficiency in people with amyotrophic lateral sclerosis (ALS). The study, which included 142 ALS patients, aimed to pinpoint clinical predictors related to lung function. neck flexor muscle weakness and bulbar onset emerged as significant indicators of respiratory risk. While the nomogram showed strong predictive power, it requires further validation in larger patient groups before it can be broadly used in clinical practice.
Key points
- The nomogram predicts respiratory insufficiency in ALS.
- Neck muscle weakness and bulbar onset are key predictors.
- Further validation is needed for clinical use.
Study Approach and Methods
This retrospective study examined 142 patients diagnosed with ALS using the revised El Escorial criteria with Awaji modifications. Conducted from August 2020 to June 2023, the research involved collecting clinical data and conducting pulmonary function tests during a single hospital stay. Respiratory insufficiency was defined as a forced vital capacity (FVC) below 80% of the predicted value.
Researchers assessed muscle strength in the neck and limbs with the Medical Research Council scale. They used multivariable logistic regression to identify independent predictors of respiratory insufficiency. The resulting nomogram underwent internal validation through bootstrap resampling with 1,000 iterations.
Identifying Key Predictors
The study found that neck flexor muscle strength and bulbar onset were significant predictors of baseline respiratory insufficiency. Weaker neck flexor muscles were linked to a lower risk (OR = 0.497), while bulbar onset increased the risk (OR = 4.392). These findings highlight the importance of these clinical features in evaluating respiratory function in ALS patients.
Nomogram Effectiveness and Future Steps
The nomogram showed good discrimination and calibration, with an area under the curve (AUC) of 0.823, indicating a strong ability to distinguish between patients with and without respiratory insufficiency. However, the researchers emphasize the need for external validation in larger, multicenter cohorts to confirm its usefulness in various clinical settings.
Further research will be crucial to explore how the nomogram can be integrated into routine ALS patient assessments, with the goal of improving early detection and management of respiratory complications.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
